Skin collagen from scleroderma patients before and after cyclosporin A treatment
- 1 January 1988
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 13 (1) , 1-3
- https://doi.org/10.1111/j.1365-2230.1988.tb00637.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Enhanced Angiogenic Capability of Monocyte-Enriched Mononuclear Cell Suspensions from Patients with Systemic SclerodermaJournal of Investigative Dermatology, 1986
- INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERSTransplantation, 1985
- Modulatory effect of sera from scleroderma patients on lymphocyte‐induced angiogenesisArthritis & Rheumatism, 1985
- Cellular immunity to collagen and laminin in sclerodermaArthritis & Rheumatism, 1985
- Lymphokine/Monokine Inhibition of Fibroblast Proliferation and Collagen Production: Role in Progressive Systemic Sclerosis (PSS)Journal of Investigative Dermatology, 1984
- Fibroblast Activation in SclerodermaScandinavian Journal of Rheumatology, 1984
- Effect of cyclosporin A (CyA) on the immune response. CyA competitively inhibits the function of monocyte/macrophage-derived T-lymphocyte-activating factor(s)Immunology Letters, 1982
- Characterization of dermal collagen in systemic sclerosisBritish Journal of Dermatology, 1979
- Collagen in the cellular and fibrotic stages of sclerodermaArthritis & Rheumatism, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970